Oligodendrogliomas comprise 5 to 20% of gliomas and are characterized by the absent expression of glial fibrillary acidic protein and by the morphology and cell markers typically associated with myelin-forming cells, oligodendrocytes. The gene discussed is GFAP; the disease is central nervous system cancer.